Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
99,881,037
-
Share change
-
+3,316,323
-
Total reported value
-
$1,371,362,373
-
Price per share
-
$13.73
-
Number of holders
-
60
-
Value change
-
+$40,180,822
-
Number of buys
-
36
-
Number of sells
-
24
Institutional Holders of CEREVEL THERAPEUTICS HLDNG I - COM (CERE) as of Q1 2021
As of 31 Mar 2021,
CEREVEL THERAPEUTICS HLDNG I - COM (CERE) was held by
60 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
99,881,037 shares.
The largest 10 holders included
Bain Capital Investors LLC, FMR LLC, PERCEPTIVE ADVISORS LLC, PRICE T ROWE ASSOCIATES INC /MD/, VANGUARD GROUP INC, Artal Group S.A., RA CAPITAL MANAGEMENT, L.P., FEDERATED HERMES, INC., ALKEON CAPITAL MANAGEMENT LLC, and Ally Bridge Group (NY) LLC.
This page lists
60
institutional shareholders reporting positions in this security
for the Q1 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.